placeNew Zealand
Contact Us
Minimally Invasive Therapies / Products / Cerebral/Somatic Oximetry / INVOS™ Cerebral/Somatic Oximetry Infant-Neonatal Sensors

Overview

The Clinical Standard in Regional Oximetry

INVOS™ OxyAlert™ NIRSensors for infants and neonates are used with the INVOS™ cerebral/somatic oximeter to generate continuous, non-invasive readings of regional blood oxygen levels in up to four site-specific areas chosen by the care team.

INVOS™ OxyAlert™ NIRSensors are applied to the skin’s surface, and are user and patient friendly, making monitoring of ischaemic threats to the brain and body safe and easy. By reporting venous weighted regional haemoglobin oxygen saturation (rSO2) in tissue directly beneath the sensor, this reflects oxygen remaining after tissue demand has been met.

Complimentary INVOS™ Analytics Tool

Learn how the INVOS™ analytics resource facilitates evaluation of regional oxygenation case data.

Learn More

Features

  • Non-invasive, continuous measurement
  • For application anywhere on the body
  • For infants and neonates < 5 kg
  • Contains a gentle, medical-grade, hypoallergenic hydrocolloid patient adhesive
  • Disposable; designed for single use
  • Non-sterile
  • Latex-free
Ordering Information
Order Code Description Unit of Measure Quantity
CNN/SNN  INVOSTM Neonatal sensor Carton 10
Specifications
Physical
Sensor Dimensions 2.72" (6.9 cm) length x 0.97" (2.5 cm) width
Depth (Thickness) 0.1005" (2.55 mm)
Weight 1.1 oz (31g)
Sensor Cable Length 5 feet (1.5 m)
Patient Adhesive Hydrocolloid (medical grade)
Operational
Calibration Precalibrated; no need for user calibration
Safety Class Continuous Operation
Type BF Class I
Environmental Requirements
Operating Temperature 60ºF – 106ºF (16ºC – 41ºC)
Humidity 20% – 80% relative humidity, non-condensing
Altitude To 10,000 feet (3,048 m)
Storage
Temperature -4ºF – 110ºF (-20ºC – 45ºC)
Humidity 20% – 80% relative humidity, non-condensing
 
REF: 12-PM-0012a
PG2

Order Information

Reflect Site-Specific Tissue Perfusion Non-Invasively

Learn more about how INVOS™ technology provides clinicians with immediate, actionable information to optimise patient care.

Learn More
About Medtronic
Minimally Invasive Therapies
Contact Us
Country Office

Level 3 - Building 5

Central Corporate Centre

666 Great South Road

Penrose, Auckland

New Zealand

©2024 Medtronic